Selexipag as third add on therapy in a thalassemic patient with pulmonary hypertension

Pulmonary Hypertension PH is a frequent clinical complication in patients with thalassemia major. PH is caused by increased pulmonary resistance induced by chronic hypoxia, iron phosphatidylserine-expressing hematologic debris, free hemoglobin, and other circulating angiotrophic factors.

Authors

Michele Correale (ORCID: https://orcid.org/0000-0002-7863-253X)

Publication Details

Journal: Open Journal of Clinical and Medical Case Reports
Published: 2024-12-31
DOI: https://doi.org/10.52768/2379-1039/2309
Primary Topic: Hemoglobinopathies and Related Disorders
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Selexipag as third add on therapy in a thalassemic patient with pulmonary hypertension

Michele Correale

Dec 31, 2024

Open Journal of Clinical and Medical Case Reports

Hemoglobinopathies and Related Disorders

article

Selexipag as third add on therapy in a thalassemic patient with pulmonary hypertension

Michele Correale

December 31, 2024article en

Abstract

Open Journal of Clinical and Medical Case ReportsVol. 10(26)

Openalex Percentile: Top 53%

Hemoglobinopathies and Related Disorders

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Selexipag as third add on therapy in a thalassemic patient with pulmonary hypertension — Michele Correale · Open Journal of Clinical and Medical Case Reports (2024) | TGRS Research Map | TGRS